Hepatitis B vaccine recombinant - Combiotech
Latest Information Update: 26 Jul 1996
At a glance
- Originator Combiotech
- Class DNA vaccines; Hepatitis B vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Hepatitis B
Most Recent Events
- 26 Jul 1996 Launched for Hepatitis B in Russia (IM)